KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Revenue (2016 - 2025)

Elevance Health (ELV) has disclosed Revenue for 17 consecutive years, with $49.8 billion as the latest value for Q2 2025.

  • On a quarterly basis, Revenue rose 17877.14% to $49.8 billion in Q2 2025 year-over-year; TTM through Dec 2025 was $98.7 billion, a 23.05% increase, with the full-year FY2025 number at -$1.4 billion, down 100.79% from a year prior.
  • Revenue was $49.8 billion for Q2 2025 at Elevance Health, up from $48.9 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $50.8 billion in Q3 2022 to a low of -$340.0 million in Q4 2024.
  • A 5-year average of $35.1 billion and a median of $36.2 billion in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: plummeted 100.78% in 2024, then soared 17877.14% in 2025.
  • Elevance Health's Revenue stood at $42.5 billion in 2021, then decreased by 8.16% to $39.0 billion in 2022, then increased by 11.77% to $43.6 billion in 2023, then tumbled by 100.78% to -$340.0 million in 2024, then surged by 14740.0% to $49.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Revenue are $49.8 billion (Q2 2025), $48.9 billion (Q1 2025), and -$340.0 million (Q4 2024).